No, We're Not All Doomed by Earth's Magnetic Field

New Post Public Reply Private Reply Replies (1) Message Board
wowhappens28
258
No, We're Not All Doomed by Earth's Magnetic Field Flip

https://news.nationalgeographic.com/2018/01/e...s-science/

Picture of Earth VIEW IMAGES
Earth, as seen by the Apollo 17 crew during their mission to the moon in 1972. This flight marked the first time an Apollo trajectory made it possible to photograph the southern polar ice cap.
PHOTOGRAPH BY NASA
By Nadia Drake
PUBLISHED JANUARY 31, 2018

Many times over our planet’s history, Earth’s magnetic poles have reversed, meaning that sometimes a compass pointing north will be aimed at Antarctica rather than the Arctic. This might sound strange, but it’s a relatively predictable quirk. Powered by the machinations of the planet’s spinning iron core, this process of geomagnetic reversal has been doing its thing without much fanfare for eons.

That is, until this week, when a book excerpt describing the phenomenon appeared online. Shortly afterward, numerous websites began trumpeting the doomsday around the corner, a geomagnetic apocalypse in which tumors run rampant, satellites fall from the sky, and life on Earth will cease to exist as we know it.

True, life on Earth almost certainly will be different than it is today in multiple thousands of years. But will these polar acrobatics have much to do with that?

First thing’s first: Are we all going to die?

Yes.

Wait, what!

We are all going to die, eventually. But chances are that we will not immediately—or even proximally—perish when Earth’s next geomagnetic reversal occurs.

Fine. So what is a geomagnetic reversal?

If geologic history repeats itself, Earth’s magnetic poles should eventually swap places. This much is undeniable. Based on the magnetic fingerprints locked into ancient rocks, we know that over the last 20 million years, magnetic north and south have flipped roughly every 200,000 to 300,000 years (this rate has not been constant over the planet’s lifetime, though). The last of these major reversals occurred about 780,000 years ago, although the Poles do wander around in between these larger flips. (What’s more, climate change seems to be shifting Earth’s geographic poles.)

That means we’re a bit overdue for a total reversal, and some data do, in fact, suggest that a geomagnetic reversal is geologically imminent. But this does not mean a polar flip-flop is going to happen tomorrow, or even any time soon, and we’d put good money on North still being in the Arctic for a while—although neither we nor anyone else knows when the next total reversal will actually happen.

OK. But if it happens soon, won’t that be bad?

Also unclear. Scientists estimate that past polar flips have been rather sluggish, with north and south migrating to opposite positions over thousands of years. This is both good and bad if you’re concerned about how a geomagnetic reversal will affect life on Earth.

The sluggish polar meander is good, because it means we have time to prepare and can do our best to ameliorate any unpleasant effects before they get really unpleasant. But it’s bad, because our planet’s magnetic field helps shield us from damaging solar and cosmic radiation, and a protracted flip means Earth might be slightly less protected from harmful space rays for longer than we would like.

It’s also not very dramatic, because it means you won’t suddenly wake up and find out that your smartphone thinks Santa’s workshop is in the Southern Hemisphere.

Bummer, that sounds boring. So what will we actually notice?

The only major, noticeable effect that’s guaranteed to occur when the polar flop is finished is that your compass needle will tell you that North is in Antarctica and South is somewhere near Canada. This will make the names of the American continents temporarily confusing (at least, on a geologic time scale) but it’ll make for a good story in classrooms.

Another interesting consequence will be that animals that use Earth’s magnetic field for navigation—including birds, salmon, and sea turtles—could get lost during their routine journeys. Eventually they will sort this out, and all other things being equal, life will go on. Lots of doomsday prophets have tried to equate geomagnetic flips with mass extinctions, but the data just aren’t there.

So there’s nothing at all to worry about?

Not exactly. It’s true that when the poles do reverse, Earth’s magnetic field could get weaker—but its strength is already quite variable, so that’s not necessarily unusual, and there’s no indication it will vanish entirely, according to NASA. Why? Because it never has.

However, if the magnetic field gets substantially weaker and stays that way for an appreciable amount of time Earth will be less protected from the oodles of high-energy particles that are constantly flying around in space. This means that everything on the planet will be exposed to higher levels of radiation, which over time could produce an increase in diseases like cancer, as well as harm delicate spacecraft and power grids on Earth.

These are consequences we can prepare for, and as far as everything below the stratosphere goes, we’ll have a nice, thick atmosphere that can also help act as a shield.

For now, we’re doing a decent job of introducing carcinogenic toxins to the environment and otherwise altering the ways in which ecosystems normally function, so there are bigger things to worry about in the short term.

That being said, one total bonus of having a weaker magnetic field is that auroras will be visible from much lower latitudes, so the nighttime skies will be even more epic.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 149

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 118

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 202

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 179

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 109

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 145

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading

Top 5 Most Recently Viewed Articles

Kimbell Royalty Partners Engages Investors at Key Conferences

Updated Category News Views 101

Kimbell Royalty Partners to Attend Notable Investor Conferences Kimbell Royalty Partners, LP (NYSE: KRP) is a prominent owner of oil and natural gas mineral and royalty interests. The company proudly manages over 129,000 gross wells across multiple states. In an effort to strengthen investor relations and share its strategic outlook, Kimbell has announced its...

Continue Reading
Karsan's Autonomous Bus Debuts at Efteling Park

Updated Category News Views 72

A Leap Towards Autonomous Mobility What we have here is Karsan breaking new ground again. They've rolled out their Autonomous e-ATAK at Efteling, the famous theme park in the Netherlands. And that's not just any park—it's a place teeming with tourists, a hotspot demanding efficient transport. Yet, these folks aren't just cranking out fancy gadgets for showing off....

Continue Reading
EyePoint Pharmaceuticals Expands Workforce with Stock Options

Updated Category News Views 301

EyePoint Pharmaceuticals Expands Workforce with Stock Options EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a dynamic biopharmaceutical company, is on a mission to enhance the lives of patients facing serious retinal diseases. Recently, the company made a notable announcement regarding the expansion of its team through the granting of non-statutory stock options to new...

Continue Reading
IonQ Shares: Insights Into Their Current Market Performance

Updated Category News Views 204

Overview of IonQ's Current Stock Performance IonQ Inc. IONQ shares have seen a notable decline recently, continuing a downward trend that’s persisted over the last couple of weeks. As the company gears up to announce its second-quarter earnings, investors are closely monitoring the developments, particularly the anticipated shift in stock momentum. Market Sentiment and...

Continue Reading
Exploring the Promising CD47 Inhibitor Drug Market Growth

Updated Category News Views 40

Understanding the CD47 Inhibitor Drug Market Gaining insights into the CD47 inhibitor drug market is crucial for recognizing the changes and advancements in cancer immunotherapy. These drugs play a vital role in the battle against cancer by harnessing the body's immune system to identify and eliminate malignant cells. CD47's Role in Cancer CD47, often referred to as the...

Continue Reading